← All supplements
Moderate evidenceGeneral health

Omega-3 (EPA/DHA)

Essential fatty acids from fish oil. Consistently lower triglycerides; effects on cardiovascular events depend on dose, formulation and population, and higher doses slightly raise the risk of atrial fibrillation.

Where to buy

  • iHerb California Gold Nutrition, Omega-3 Premium Fish Oil, 100 Fish Gelatin Softgels (1,100 mg per Softgel) Ships to 180+ countries · welcome discount for new customers
    View on iHerb

Each store sells its own product: check brand, amount and price on the store page before buying. Prices change; the date shows when we last checked.

Referral link — this site may earn a commission on purchases.

What the science says

  • Triglyceride reduction Strong evidence

    Doses of 2–4 g/day of EPA/DHA lower plasma triglycerides consistently and dose-dependently: about 15% on average across long-term trials, and 30% or more at 4 g/day in people with very high triglycerides.

    Who was studied
    86 randomized trials lasting at least 12 months (162,796 adults at varying cardiovascular risk), plus the American Heart Association review of prescription-dose trials in people with high or very high triglycerides.
    Result
    Fasting triglycerides and other blood lipids.
    Effect size
    Long-chain omega-3 lowered triglycerides by about 15% in a dose-dependent way (high-certainty evidence); 4 g/day lowered very high triglycerides (500 mg/dL or more) by 30% or more, with EPA-only and EPA+DHA products roughly comparable.
    Limitations
    Triglycerides are a surrogate marker, and lowering them does not guarantee fewer heart attacks; EPA+DHA at 4 g/day can raise LDL cholesterol in people with very high triglycerides.
    Sources
    [1] [2]
  • Cardiovascular protection Moderate evidence

    Mixed results: REDUCE-IT showed fewer cardiovascular events with high-dose purified EPA (4 g/day) in high-risk patients on statins, but STRENGTH, with 4 g/day of EPA+DHA, found no benefit, and large meta-analyses show at most a small reduction in coronary events and little or no effect on overall mortality.

    Who was studied
    8,179 statin-treated high-risk patients in REDUCE-IT, 13,078 in STRENGTH, and meta-analyses of 86 trials (162,796 participants) and 40 trials (135,267 participants).
    Result
    Major cardiovascular events, heart attacks, coronary events and all-cause mortality.
    Effect size
    REDUCE-IT: events in 17.2% vs 22.0% (HR 0.75, 95% CI 0.68 to 0.83); STRENGTH: 12.0% vs 12.2% (HR 0.99, 95% CI 0.90 to 1.09); Cochrane: all-cause mortality RR 0.97 (95% CI 0.93 to 1.01), coronary events RR 0.91 (95% CI 0.85 to 0.97), 167 people treated to prevent one event; second meta-analysis: heart attack RR 0.87 (95% CI 0.80 to 0.96).
    Limitations
    REDUCE-IT was funded by the drug's maker and tested a prescription EPA drug, so its result does not transfer to ordinary fish oil capsules; STRENGTH used corn oil as comparator, and the absolute benefit in lower-risk people is small.
    Sources
    [2] [3] [4] [5]
  • Mood and cognition benefits Limited evidence

    In diagnosed depression, omega-3 gives a small benefit that is probably not clinically meaningful and may be inflated by bias; EPA-rich formulas look better than DHA-rich ones. For memory and cognitive decline, the effect is at most modest.

    Who was studied
    34 placebo-controlled trials with 1,924 adults with major depression; 26 trials with 2,160 participants with depressive symptoms; 14 trials with 26,881 adults aged 40 or older without dementia or with mild cognitive impairment.
    Result
    Depression rating scales, remission and response; cognitive scores on the MMSE.
    Effect size
    Depression SMD −0.40 (95% CI −0.64 to −0.16), about 2.5 points on the Hamilton scale where 3 points is the smallest meaningful change, with no difference in remission or response; formulas with at least 60% EPA did better (SMD −1.03) than DHA-rich ones; MMSE effect size 0.16 (95% CI 0.01 to 0.32).
    Limitations
    Cochrane rated the depression evidence very low certainty, with high heterogeneity and a likely bias toward positive results; the cognition result comes from an overview of reviews and is small and borderline.
    Sources
    [7] [8] [9]
  • Higher risk of atrial fibrillation Moderate evidence

    Long-term trials show that omega-3 supplements slightly raise the risk of atrial fibrillation, an irregular heart rhythm, and the risk grows with dose, especially above 1 g/day.

    Who was studied
    7 cardiovascular outcome trials with 81,210 adults (mean age 65, 39% women) followed for about 4.9 years.
    Result
    New atrial fibrillation, reported as an outcome, adverse event or cause of hospitalization.
    Effect size
    HR 1.25 (95% CI 1.07 to 1.46) overall; 1.49 above 1 g/day versus 1.12 at 1 g/day or less, with risk rising about 11% per extra gram; in REDUCE-IT, hospitalization for atrial fibrillation was 3.1% vs 2.1%.
    Limitations
    Atrial fibrillation was not a primary outcome in most trials and the absolute increase is small; participants were older adults with cardiovascular risk, so the risk for young healthy users is less clear.
    Sources
    [6] [3]

Dosage & safety

Studied dose1–2 g/day of combined EPA+DHA for general health; higher doses only under medical guidance. Prefer products with third-party purity certification.
SafetyWell tolerated. High doses may cause gastrointestinal discomfort and slightly increase the risk of bleeding. The risk of atrial fibrillation rises with dose, more so above 1 g/day; people with heart rhythm problems or on anticoagulants should talk to their doctor first.

How to take it

TimingTiming does not matter; the effect builds over weeks of consistent intake.
With food?With a meal containing fat — absorption is substantially better and fishy reflux is far less likely.
Worth knowingStore it in the fridge and smell a capsule occasionally: rancid oil is common, delivers oxidised fat, and is the usual cause of the aftertaste.

Interactions

With medications

  • warfarin, DOACs, aspirin and clopidogrel

    Fish oil has a mild antiplatelet effect that adds to anticoagulant and antiplatelet drugs, mainly at doses above 3 g/day. keep to 1 g/day or discuss higher doses with your prescriber, and stop before surgery

  • blood pressure medication

    Omega-3 lowers blood pressure modestly, which can add to antihypertensive drugs. usually helpful rather than harmful, but monitor if your pressure already runs low

With other supplements

  • high-dose vitamin E

    Both have antiplatelet activity; together the bleeding risk is greater than either alone. avoid combining high doses

  • garlic extract and ginkgo biloba

    Additive platelet inhibition. avoid stacking before surgery or on anticoagulants

Well-established interactions only — this is not a complete list. Always tell your doctor and pharmacist what you take.

Frequently asked questions

Does omega-3 fish oil lower triglycerides?

Yes — this is the strongest evidence for omega-3. Doses of 2–4 g/day of EPA/DHA lower triglycerides consistently, typically by 15–30%.

Does omega-3 prevent heart attacks?

The evidence for omega-3 and heart attacks is moderate and mixed. The REDUCE-IT trial found fewer cardiovascular events with 4 g/day of purified EPA in high-risk patients, but low-dose omega-3 supplements show little or no effect in the general population.

How much omega-3 per day?

For general health, take 1–2 g/day of combined EPA+DHA, with higher omega-3 doses only under medical guidance. Choose products with third-party purity certification.

Is fish oil safe with blood thinners?

Omega-3 fish oil has a mild antiplatelet effect that adds to warfarin, DOACs, aspirin and clopidogrel, mainly above 3 g/day. Keep to 1 g/day or discuss higher doses with your prescriber, and stop fish oil before surgery.

Scientific references

  1. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association
    Skulas-Ray AC, Wilson PWF, Harris WS, et al. — Circulation, 2019
  2. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
    Abdelhamid AS, Brown TJ, Brainard JS, et al. — Cochrane Database Syst Rev, 2020
  3. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
    Bhatt DL, Steg PG, Miller M, et al. — N Engl J Med, 2019
  4. Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial
    Nicholls SJ, Lincoff AM, Garcia M, et al. — JAMA, 2020
  5. Effect of Omega-3 Dosage on Cardiovascular Outcomes: An Updated Meta-Analysis and Meta-Regression of Interventional Trials
    Bernasconi AA, Wiest MM, Lavie CJ, et al. — Mayo Clin Proc, 2021
  6. Effect of Long-Term Marine ɷ-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis
    Gencer B, Djousse L, Al-Ramady OT, et al. — Circulation, 2021
  7. Omega-3 fatty acids for depression in adults
    Appleton KM, Voyias PD, Sallis HM, et al. — Cochrane Database Syst Rev, 2021
  8. Efficacy of omega-3 PUFAs in depression: A meta-analysis
    Liao Y, Xie B, Zhang H, et al. — Transl Psychiatry, 2019
  9. Omega-3 Polyunsaturated Fatty Acids and Cognitive Decline in Adults with Non-Dementia or Mild Cognitive Impairment: An Overview of Systematic Reviews
    Barros MI, Brandão T, Irving SC, et al. — Nutrients, 2025

Related in General health